Brainstorm Cell Therapeutics Inc  

(Public, OTCBB:BCLI)   Watch this stock  
Find more results for OTC:BCLI
0.319
0.000 (0.00%)
Jul 31 - Close
OTCBB data delayed by 15 mins - Disclaimer
Currency in USD
Range     -
52 week 0.10 - 0.38
Open     -
Vol / Avg. 0.00/1.34M
Mkt cap 72.58M
P/E     -
Div/yield     -
EPS -0.03
Shares 227.16M
Beta 1.01
Inst. own 15%

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -189.87% -97.63%
Return on average equity -470.53% -145.78%
Employees 14 -
CDP Score - -

Address

34TH FLOOR, 605 THIRD AVENUE
NEW YORK, NY 10158
United States - Map
+1-646-6663188 (Phone)
+1-302-6555049 (Fax)

Website links

Description

Brainstorm Cell Therapeutics Inc. (Brainstorm) is a biotechnology company developing adult stem cell therapies for debilitating neurodegenerative disorders, such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Multiple Sclerosis (MS), and Parkinson�s disease (PD). These diseases have limited treatment options and as such represent unmet medical needs. The Company�s NurOwn technology is based on a differentiation protocol, which induces differentiation of the bone marrow-derived mesenchymal stem cells into neuron-supporting cells, MSC-NTF cells, capable of releasing several neurotrophic factors, including Glial-derived neurotrophic factor (GDNF) and Brain-derived neurotrophic factor (BDNF), Vascular endothelial growth factor (VEGF) and Hepatocyte growth factor (HGF), which are critical for the growth, survival and differentiation of developing neurons.

Officers and directors

Irit Arbel Chairman of the Board
Age: 53
Chaim Lebovits President
Age: 42
Anthony Fiorino M.D., Ph.D. Chief Executive Officer
Age: 46
Liat Sossover Chief Financial Officer
Age: 44
Uri Yablonka Chief Operating Officer, Director
Age: 37
Adrian Harel Ph.D. Director - Research and Development
Age: 56
Mordechai Friedman Independent Director
Age: 61
Alon Pinkas Independent Director
Age: 51
Chen Schor CPA Independent Director
Age: 41
Robert G. Shorr Ph.D. Independent Director
Age: 59